{"id":12303,"date":"2026-07-06T11:01:47","date_gmt":"2026-07-06T11:01:47","guid":{"rendered":"https:\/\/www.bedfont.com\/?p=12303"},"modified":"2026-07-06T11:01:50","modified_gmt":"2026-07-06T11:01:50","slug":"asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma","status":"publish","type":"post","link":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/","title":{"rendered":"Asthma care is evolving. How FeNO testing is changing the way we treat asthma"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\"><strong><em>Over 1,200 NObreath\u00ae FeNO devices sold since the 2024 UK guideline update.<\/em><\/strong><\/h2>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.bedfont.com\/\">Bedfont\u00ae Scientific Limited<\/a>, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for asthma care with the NObreath\u00ae, welcomes the news that over 1 million people with asthma are now using combination inhalers<sup>1<\/sup> following the joint <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng245\">2024 asthma guidelines<\/a> from the National Institute for Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN)<sup>2<\/sup>. This milestone marks a significant shift in asthma management in the UK, with NObreath\u00ae sales exceeding 1,240 units since the update.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"605\" src=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/06\/Child-NObreath\u00ae-Test-1024x605.png\" alt=\"Personalised Asthma Care\" class=\"wp-image-12218\" srcset=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/06\/Child-NObreath\u00ae-Test-1024x605.png 1024w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/06\/Child-NObreath\u00ae-Test-300x177.png 300w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/06\/Child-NObreath\u00ae-Test-768x454.png 768w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/06\/Child-NObreath\u00ae-Test-1536x908.png 1536w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/06\/Child-NObreath\u00ae-Test-2048x1210.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">The well-known blue reliever inhaler helps control symptoms but doesn\u2019t address the underlying airway inflammation, the key driver of asthma. Airway inflammation cannot be seen or felt, so whilst patients may not be experiencing any symptoms, the inflammation could be building below the surface, leading to an exacerbation or asthma attack. The NObreath\u00ae FeNO device can quickly measure airway inflammation, giving clinicians valuable objective insight enabling them to tailor treatment effectively.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Switching patients to combination inhalers ensures not only symptom relief but also inflammation control. The updated guideline reflects a growing emphasis on prevention-focused asthma care, including earlier anti-inflammatory treatment and reduced reliance on symptom relief alone.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cSeeing more than 1 million people now using combination inhalers marks a significant milestone in the evolution of asthma care. It reflects a growing emphasis on prevention-focused asthma care, including earlier anti-inflammatory treatment and reduced reliance on symptom relief alone. At Bedfont\u00ae, we\u2019re proud that FeNO testing is helping support this shift towards more proactive, personalised care. Through the NObreath\u00ae, we are helping clinicians gain objective insight into airway inflammation, supporting better-informed decisions and improved long-term outcomes. Everyone deserves access to better asthma care, empowering them to live healthier lives with greater confidence and control.\u201d Said <strong>Jason Smith, CEO at Bedfont\u00ae.<\/strong><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Media-1-8B8DFEBA-8E79-4160-B20C-CB715896E096-1024x768.jpg\" alt=\"\" class=\"wp-image-12306\" srcset=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Media-1-8B8DFEBA-8E79-4160-B20C-CB715896E096-1024x768.jpg 1024w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Media-1-8B8DFEBA-8E79-4160-B20C-CB715896E096-300x225.jpg 300w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Media-1-8B8DFEBA-8E79-4160-B20C-CB715896E096-768x576.jpg 768w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Media-1-8B8DFEBA-8E79-4160-B20C-CB715896E096-1536x1152.jpg 1536w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Media-1-8B8DFEBA-8E79-4160-B20C-CB715896E096-2048x1536.jpg 2048w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Media-1-8B8DFEBA-8E79-4160-B20C-CB715896E096-640x480.jpg 640w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Bedfont\u00ae works closely with its UK distributor, <a href=\"https:\/\/www.intermedical.co.uk\/\">Intermedical UK<\/a>, to expand access to FeNO testing nationwide. Intermedical launched its <a href=\"https:\/\/www.intermedicaldirect.co.uk\/news\/nobreath-3000-complete-overview\">NObreath\u00ae 3000 campaign<\/a> last year, signifying a major milestone of 3,000 NObreath\u00ae sales in the UK. It also reported growing sales following the guideline update, with over 1,240 devices sold since November 2024 alone, demonstrating the impact of national guidance on asthma care.<\/p>\n<\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">A FeNO test with the NObreath\u00ae can assess inflammation by measuring nitric oxide (NO) levels in exhaled breath, a biomarker of airway inflammation. The test is quick, easy, and non-invasive, supporting clinicians&#8217; decision-making and treatment plans aligned with evolving guidelines. This milestone reflects a broader shift in asthma care towards precision medicine, biomarker-driven approaches, and more personalised management, all aimed at improving patient outcomes worldwide.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The NObreath\u00ae FeNO device has been improving asthma care for over 15 years. To learn more, please visit the website <a href=\"https:\/\/www.nobreathfeno.com\/\">here<\/a>.<\/p>\n\n\n\n<h4 class=\"wp-block-heading has-text-align-left\"><strong>References<\/strong><\/h4>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u201cI no longer feel asthmatic\u201d: more than a million people now using new style inhalers [Internet]. NICE website: The National Institute for Health and Care Excellence. NICE; 2026 [cited 2026 May 6]. Available from: <a href=\"https:\/\/www.nice.org.uk\/news\/articles\/-i-no-longer-feel-asthmatic-more-than-a-million-people-now-using-new-style-inhalers\">https:\/\/www.nice.org.uk\/news\/articles\/-i-no-longer-feel-asthmatic-more-than-a-million-people-now-using-new-style-inhalers<\/a>?<\/li>\n\n\n\n<li>National Institute for Health and Care Excellence. Overview | Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) | Guidance | NICE [Internet]. Nice.org.uk. NICE; 2024. Available from: <a href=\"https:\/\/www.nice.org.uk\/guidance\/NG245\">https:\/\/www.nice.org.uk\/guidance\/NG245<\/a><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Over 1,200 NObreath\u00ae FeNO devices sold since the 2024 UK guideline update. Bedfont\u00ae Scientific Limited, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for asthma care with the NObreath\u00ae, welcomes the news that over 1 million people with asthma are now using combination inhalers1 following the joint 2024 asthma guidelines [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":12319,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[60,55],"tags":[8,9,157,168,154,155,11,235,156,236],"class_list":["post-12303","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bedfont-news","category-nobreath","tag-bedfont","tag-bedfont-scientific","tag-breath-analysis","tag-feno","tag-feno-testing","tag-improving-asthma-care","tag-innovating-health","tag-nice-asthma-guidelines","tag-nobreath","tag-personalised-asthma-care"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Asthma Care is Moving Towards Personalised Care<\/title>\n<meta name=\"description\" content=\"Bedfont\u00ae welcomes the news that over 1 million people are now using combination inhalers. This milestone reflects a shift in asthma care.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Asthma Care is Moving Towards Personalised Care\" \/>\n<meta property=\"og:description\" content=\"Bedfont\u00ae welcomes the news that over 1 million people are now using combination inhalers. This milestone reflects a shift in asthma care.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/\" \/>\n<meta property=\"og:site_name\" content=\"Bedfont Scientific Ltd.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Bedfontltd\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-06T11:01:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-06T11:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Article-Featured-Images-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2240\" \/>\n\t<meta property=\"og:image:height\" content=\"1260\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jemma Carter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BedfontLtd\" \/>\n<meta name=\"twitter:site\" content=\"@BedfontLtd\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jemma Carter\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/\"},\"author\":{\"name\":\"Jemma Carter\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#\\\/schema\\\/person\\\/20d6eae572713673eaee5915e03dc2d3\"},\"headline\":\"Asthma care is evolving. How FeNO testing is changing the way we treat asthma\",\"datePublished\":\"2026-07-06T11:01:47+00:00\",\"dateModified\":\"2026-07-06T11:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/\"},\"wordCount\":531,\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Article-Featured-Images-1.png\",\"keywords\":[\"Bedfont\",\"Bedfont Scientific\",\"Breath analysis\",\"FeNO\",\"FeNO Testing\",\"Improving asthma care\",\"innovating health\",\"NICE Asthma Guidelines\",\"NObreath\",\"Personalised Asthma Care\"],\"articleSection\":[\"Bedfont news\",\"NObreath\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/\",\"name\":\"Asthma Care is Moving Towards Personalised Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Article-Featured-Images-1.png\",\"datePublished\":\"2026-07-06T11:01:47+00:00\",\"dateModified\":\"2026-07-06T11:01:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#\\\/schema\\\/person\\\/20d6eae572713673eaee5915e03dc2d3\"},\"description\":\"Bedfont\u00ae welcomes the news that over 1 million people are now using combination inhalers. This milestone reflects a shift in asthma care.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Article-Featured-Images-1.png\",\"contentUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Article-Featured-Images-1.png\",\"width\":2240,\"height\":1260,\"caption\":\"Personalised Asthma Care\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Asthma care is evolving. How FeNO testing is changing the way we treat asthma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/\",\"name\":\"Bedfont Scientific Ltd.\",\"description\":\"World leaders in breath analysis.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#\\\/schema\\\/person\\\/20d6eae572713673eaee5915e03dc2d3\",\"name\":\"Jemma Carter\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g\",\"caption\":\"Jemma Carter\"},\"url\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/author\\\/jemmac\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Asthma Care is Moving Towards Personalised Care","description":"Bedfont\u00ae welcomes the news that over 1 million people are now using combination inhalers. This milestone reflects a shift in asthma care.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/","og_locale":"nl_NL","og_type":"article","og_title":"Asthma Care is Moving Towards Personalised Care","og_description":"Bedfont\u00ae welcomes the news that over 1 million people are now using combination inhalers. This milestone reflects a shift in asthma care.","og_url":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/","og_site_name":"Bedfont Scientific Ltd.","article_publisher":"https:\/\/www.facebook.com\/Bedfontltd\/","article_published_time":"2026-07-06T11:01:47+00:00","article_modified_time":"2026-07-06T11:01:50+00:00","og_image":[{"width":2240,"height":1260,"url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Article-Featured-Images-1.png","type":"image\/png"}],"author":"Jemma Carter","twitter_card":"summary_large_image","twitter_creator":"@BedfontLtd","twitter_site":"@BedfontLtd","twitter_misc":{"Geschreven door":"Jemma Carter","Geschatte leestijd":"3 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/#article","isPartOf":{"@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/"},"author":{"name":"Jemma Carter","@id":"https:\/\/www.bedfont.com\/nl\/#\/schema\/person\/20d6eae572713673eaee5915e03dc2d3"},"headline":"Asthma care is evolving. How FeNO testing is changing the way we treat asthma","datePublished":"2026-07-06T11:01:47+00:00","dateModified":"2026-07-06T11:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/"},"wordCount":531,"image":{"@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Article-Featured-Images-1.png","keywords":["Bedfont","Bedfont Scientific","Breath analysis","FeNO","FeNO Testing","Improving asthma care","innovating health","NICE Asthma Guidelines","NObreath","Personalised Asthma Care"],"articleSection":["Bedfont news","NObreath"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/","url":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/","name":"Asthma Care is Moving Towards Personalised Care","isPartOf":{"@id":"https:\/\/www.bedfont.com\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/#primaryimage"},"image":{"@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Article-Featured-Images-1.png","datePublished":"2026-07-06T11:01:47+00:00","dateModified":"2026-07-06T11:01:50+00:00","author":{"@id":"https:\/\/www.bedfont.com\/nl\/#\/schema\/person\/20d6eae572713673eaee5915e03dc2d3"},"description":"Bedfont\u00ae welcomes the news that over 1 million people are now using combination inhalers. This milestone reflects a shift in asthma care.","breadcrumb":{"@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/#primaryimage","url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Article-Featured-Images-1.png","contentUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2026\/07\/Article-Featured-Images-1.png","width":2240,"height":1260,"caption":"Personalised Asthma Care"},{"@type":"BreadcrumbList","@id":"https:\/\/www.bedfont.com\/nl\/asthma-care-is-evolving-how-feno-testing-is-changing-the-way-we-treat-asthma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bedfont.com\/nl\/"},{"@type":"ListItem","position":2,"name":"Asthma care is evolving. How FeNO testing is changing the way we treat asthma"}]},{"@type":"WebSite","@id":"https:\/\/www.bedfont.com\/nl\/#website","url":"https:\/\/www.bedfont.com\/nl\/","name":"Bedfont Scientific Ltd.","description":"World leaders in breath analysis.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bedfont.com\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Person","@id":"https:\/\/www.bedfont.com\/nl\/#\/schema\/person\/20d6eae572713673eaee5915e03dc2d3","name":"Jemma Carter","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/73c0e92289ac4fce57b76e6fc8a583f18caf0d2a0d8fee7e38d3c3a9d897b1bd?s=96&d=mm&r=g","caption":"Jemma Carter"},"url":"https:\/\/www.bedfont.com\/nl\/author\/jemmac\/"}]}},"_links":{"self":[{"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/posts\/12303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/comments?post=12303"}],"version-history":[{"count":6,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/posts\/12303\/revisions"}],"predecessor-version":[{"id":12318,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/posts\/12303\/revisions\/12318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/media\/12319"}],"wp:attachment":[{"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/media?parent=12303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/categories?post=12303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/tags?post=12303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}